Price
CHART BY
Frequently asked questions
What is Delcath Systems's market capitalization?
The market capitalization of Delcath Systems is $366.91M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is Delcath Systems's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for Delcath Systems is 1,208.14. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for Delcath Systems?
Delcath Systems's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $0.0086. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Delcath Systems's stock?
Currently, 7 analysts cover Delcath Systems's stock, with a consensus target price of $23.14. Analyst ratings provide insights into the stock's expected performance.
What is Delcath Systems's revenue over the trailing twelve months?
Over the trailing twelve months, Delcath Systems reported a revenue of $79.60M.
What is the EBITDA for Delcath Systems?
Delcath Systems's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $6.19M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Delcath Systems?
Delcath Systems has a free cash flow of $12.04M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Delcath Systems have, and what sector and industry does it belong to?
Delcath Systems employs approximately 96 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.
What is the free float of Delcath Systems's shares?
The free float of Delcath Systems is 33.74M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $366.91M
- EPS (TTM)
- $0.0086
- Free Float
- 33.74M
- P/E ratio (TTM)
- 1,208.14
- Revenue (TTM)
- $79.60M
- EBITDA (TTM)
- $6.19M
- Free Cashflow (TTM)
- $12.04M
Pricing
- 1D span
- $10.32$10.79
- 52W span
- $8.12$18.20
Analyst Ratings
The price target is $23.14 and the stock is covered by 7 analysts.
Buy
7
Hold
0
Sell
0
Information
Delcath Systems, Inc. is an oncology company, which engages in the treatment of primary and metastatic liver cancers. Its products include CHEMOSAT and HEPZATO. The company was founded on August 5, 1988 and is headquartered in Queensbury, NY.
- Employees
- 96
- Industries
- Medical Specialties
- Sector
- Health Care
Identifier
- Primary Ticker
- DCTH
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet